Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1
- PMID: 15659039
- DOI: 10.1111/j.1067-1927.2005.130110.x
Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1
Abstract
In a 16-patient study, cultured fibroblast populations from normal skin were able to replicate an average of 14.8 +/- 2.2 times before becoming senescent, while fibroblast populations from the ulcer bed reached the end of their replicative life span after 7.2 +/- 1.9 population doublings (p= 0.001). Fibroblast populations from 10 of 16 pressure ulcers became senescent after fewer than five population doublings, whereas when populations of fibroblasts from adjacent normal skin were studied, only 2 of 16 became senescent within this same time period. In addition, only an occasional fibroblast from normal skin stained positively for senescence-associated beta-galactosidase compared to approximately 50% of equally aged ulcer bed fibroblasts (p = 0.0060). Senescent ulcer bed fibroblasts secreted significantly more plasmin than early passage ulcer bed fibroblasts (p= 0.0237), nearly six times as much plasmin as early passage normal skin fibroblasts (p < 0.0001), three and a half times the level of normal skin fibroblasts of the same age (11.52 +/- 4.58 microg/mg protein; p= 0.0003), and more than one and a half times the level of senescent normal skin fibroblasts (p= 0.0525). Senescent pressure ulcer fibroblasts generated significantly more plasminogen activator inhibitor-1 (1179.27 +/- 25.37 ng/mg protein) than normal skin fibroblasts of the same age (132.16 +/- 16.20 ng/mg protein; p = 0.0357). Also, senescent ulcer bed fibroblasts produced higher levels of transforming growth factor-beta1, but these were not significantly different from senescent normal skin fibroblasts. Although senescent ulcer fibroblasts produce elevated levels of plasminogen activator inhibitor-1 and transforming growth factor-beta1, the ratio of these factors to plasmin levels suggests that this may have little influence on extracellular matrix synthesis or maintenance in the chronic wound. These data show that cultured fibroblasts from most patient pressure ulcers profile a wound environment that is associated with an increasing population of senescent fibroblasts; however, factors within the chronic wound environment that promote cellular senescence remain unclear. We have proposed that a prolonged inflammatory response may be a contributing factor to the chronic wound condition.
Similar articles
-
Pressure-induced cellular senescence: a mechanism linking venous hypertension to venous ulcers.J Surg Res. 2005 Mar;124(1):112-7. doi: 10.1016/j.jss.2004.09.013. J Surg Res. 2005. PMID: 15734488
-
Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts.J Cell Physiol. 1998 Jan;174(1):90-8. doi: 10.1002/(SICI)1097-4652(199801)174:1<90::AID-JCP10>3.0.CO;2-S. J Cell Physiol. 1998. PMID: 9397159
-
Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome.J Cell Physiol. 1994 Dec;161(3):571-9. doi: 10.1002/jcp.1041610321. J Cell Physiol. 1994. PMID: 7962138
-
The cell biology of aging.Clin Geriatr Med. 1985 Feb;1(1):15-27. Clin Geriatr Med. 1985. PMID: 3913498 Review.
-
Iron accumulation during cellular senescence.Ann N Y Acad Sci. 2004 Jun;1019:365-7. doi: 10.1196/annals.1297.063. Ann N Y Acad Sci. 2004. PMID: 15247045 Review.
Cited by
-
Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis.bioRxiv [Preprint]. 2024 Jul 8:2024.07.04.602041. doi: 10.1101/2024.07.04.602041. bioRxiv. 2024. Update in: PLoS Comput Biol. 2025 Apr 15;21(4):e1012298. doi: 10.1371/journal.pcbi.1012298. PMID: 39026713 Free PMC article. Updated. Preprint.
-
The Lipid Portion of Activated Platelet-Rich Plasma Significantly Contributes to Its Wound Healing Properties.Adv Wound Care (New Rochelle). 2015 Feb 1;4(2):100-109. doi: 10.1089/wound.2014.0589. Adv Wound Care (New Rochelle). 2015. PMID: 25713752 Free PMC article.
-
Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis.PLoS Comput Biol. 2025 Apr 15;21(4):e1012298. doi: 10.1371/journal.pcbi.1012298. eCollection 2025 Apr. PLoS Comput Biol. 2025. PMID: 40233102 Free PMC article.
-
Progenitor cell therapy for sacral pressure sore: a pilot study with a novel human chronic wound model.Stem Cell Res Ther. 2014 Jan 29;5(1):18. doi: 10.1186/scrt407. Stem Cell Res Ther. 2014. PMID: 24476740 Free PMC article. Clinical Trial.
-
Stem Cells for Cutaneous Wound Healing.Biomed Res Int. 2015;2015:285869. doi: 10.1155/2015/285869. Epub 2015 Jun 2. Biomed Res Int. 2015. PMID: 26137471 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical